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Non-Typhoidal Salmonella spp. (NTS) causing Salmonellosis remains a significant health 
burden in both developing and developed countries. Due to overcrowded hospitals and a 
lack of adequate diagnostic testing, Vietnam is a hotspot for drug resistance.  Pork accounts 
for over 70% of total meat consumed within Vietnam, and contamination with NTS remains 
high. This study aimed to analyse the patterns of NTS serotypes and AMR of strains 
between 2014/5 to 2018 and also to determine whether the Colistin resistance seen in the 
2014/5 study was caused by mcr-1. 
Methods 
To determine the presence of mcr-1, strains from a previous study, PigRISK 2014/5 were 
selected. The serotype was checked following the Kauffmann and White scheme, and 
Colistin antimicrobial resistance (AMR) performed using both disc diffusion and broth 
microdilution. Polymerase chain reaction (PCR) was used to determine the presence of mcr-
1. Samples representing 2018 were collected as part of the SafePORK study and processed 
for NTS isolation, serotyping and AMR for 12 antimicrobials.  
Results 
In the PigRISK strains, mcr-1 was not identified on either the chromosome or plasmid. From 
analysing serotypes and AMR between 2014/5 and 2018, a significant increase of NTS 
prevalence was observed from 44.7% to 78.6%. Antimicrobial resistance also remained 
high, and the number of strains showing multidrug resistance had increased between 
studies. 
Conclusion  
This study was limited to determining the presence of one gene causing Colistin resistance, 
further work is required to identify the exact cause of observed resistance. The collection of 
samples representing 2018 was limited to one province, one sample type and one section of 
the pork value chain. To aid comparison, it would be necessary to obtain a variety of 
samples. This study demonstrated why the control of antimicrobials within the agriculture 






1.1 Public Health burden 
 
Salmonellosis, caused by Non-Typhoidal Salmonella spp. (NTS), remains a significant 
health burden in both humans and animals within developing and developed countries (1). 
Foodborne illness resulting in diarrhoea continues to be one of the most prevalent infections 
worldwide causing approximately 600 million cases in 2010 (2). In 2016, the global number 
of deaths due to diarrhoeal disease reached 1.66 million (figure 1.1). 
 
 
Figure 1.1 Annual number of global deaths by cause, 2016 (3) 
 
NTS along with Enteropathogenic Escherichia coli, Enterotoxigenic E. coli and 
Campylobacter spp. continue to be the predominant bacterial causes of diarrhoeal disease 
(3). The burden of NTS causing clinical gastroenteritis in 2005 was estimated to cause 
around 93.8 million cases of foodborne illness, resulting in 155,000 deaths (1).  
Estimates for the number of cases and deaths caused by NTS in East-Asia was predicted at 
53,429,000 and 88,200 respectively, in comparison Europe was estimated at 5,065,000 and 
8400 (1). East Asia accounted for 56.98% of the global total of NTS cases, clearly 
highlighting an issue within this region.  
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NTS infections are likely to be underreported within developing countries due to limited 
diagnostic resources and the readily available antimicrobials over the pharmacy counter 
without prescription. Most infected individuals will not seek any medical help but will self-
diagnose and take a course of antimicrobials. Therefore the public health burden is likely to 
be more severe than estimated in this review.  
1.2 Salmonella background  
 
The first Salmonella strain was isolated from the intestine of a pig by Daniel Elmer Salmon 
and Theobald Smith in 1886, it was primarily given the name Salmonella cholerasuis (4). 
Salmonella spp. belongs to the family Enterobacteriacae, are Gram negative, bacillus 
shaped, non-spore forming and predominantly motile with peritrichous flagella. In 1926 
Phillip Bruce White began analysing the major antigens present on the surface of the 
bacteria, this work was later extended in 1941 by Fritz Kauffmann (5), leading to the 
introduction of the Kauffman and White serotyping scheme. Due to the development of 
serological techniques during the late 19th century, new serotypes were discovered and 
named after either the clinical condition caused or the host infected (5). The original naming 
of S. cholerasuis caused much confusion as it referred to both a species and a serotype. In 
order to address this the name was changed in 1986 to S. enterica (6). Confusion still arises 
with Salmonella classification and remains a constant debate.  
Current Salmonella taxonomy consists of two species, S. enterica and S. bongori (figure 
1.2). The antigenic formulae of serotypes is defined and maintained by the World Health 
Organisation (WHO) Collaborating Centre for Reference and Research on Salmonella at the 
Pasteur Institute (7). The formulae is reviewed and updated every 10 to 20 years, the latest 
edition, 2007, describes 2,579 serotypes recognised within these species (7). 59% of 
serotypes are grouped into S. enterica subspecies enterica, and is these serotypes which 
are responsible for 99% of human and warm-blooded animal infections (6).  
Subspecies enterica serotypes are further differentiated into Typhoidal and Non-Typhoidal 
Salmonella. Included within the Typhoidal group are S. Typhi and S. Paratyphi, the 
aetiological agents of typhoid fever and paratyphoid fever respectively. The clinical 
symptoms for these serotypes are indistinguishable, therefore the term enteric fever is 
commonly used to describe both (8). Serotypes in S. enterica not causing enteric fever are 
classified as Non-Typhoidal Salmonella (NTS), included in this group are S. Typhimurium, S. 





Figure 1.2 Taxonomy of Salmonella spp. Including genus, species, subspecies, serotype and 
disease (9).  
 
NTS can also be differentiated based on whether the serotype is host restricted or host non-
specific. Host restricted serotypes are limited to infecting a single specific host, they include 
S. Gallinarum (poultry) and S. Abortusequi (horses), whereas host non-specific serotypes 
including S. Typhimurium and S. Derby have the ability to cause infections in numerous 
hosts (10). 
Epidemiological investigations of S. enterica have always relied heavily upon the Kauffman 
and White serotyping technique. However, this method has numerous limitations including 
high expense, low throughput and skill dependent. Other phenotypic approaches such as 
phage typing have been used for the characterisation of Salmonella strains. It provides a 
rapid, accurate and cheap alternative for differentiating particular serotypes into phage types 
as a result of their susceptibility to phage lysis (11). Various molecular methods have also 
been proposed as potential alternatives, including Multi-Locus Sequence Testing (MLST) 
(12). MLST characterises bacterial species based upon the sequence of seven house-
keeping genes. MLST remains superior to both serotyping and phage typing, it is a valuable 
tool for identification and elucidating the diversity of known serotypes and also facilitating 






1.3 Main reservoirs and transmission 
 
NTS are important zoonoses due to the enormous animal reservoir, including food animals 
such as poultry, porcine and cattle; but also household pets (14).  The consumption of 
contaminated food is the major route of transmission to humans. NTS remain viable in 
undercooked animal products, have the capability of surviving several weeks in a dry 
environment and even several months in present in water (15)(3). Direct human to human 
transmission is possible, but is far less common. 
1.4 Salmonella pathogenicity 
 
Salmonella displays a characteristic pathogenesis, in which it induces its own phagocytosis 
into intestinal epithelial cells (16). Structures, including two type three secretion systems 
(T3SS), required for invasion are encoded on a pathogenicity island. Using the first T3SS the 
organism is able to inject effector proteins into the intestinal cell, triggering actin cytoskeleton 
ruffling and ultimately engulfing the bacteria into a vesicle structure (8). To avoid the 
activation of the immune system, Salmonella causes an alteration of the vesicle structure by 
injecting effector proteins into the vacuole using the second T3SS (8). Salmonella which lack 
the essential mechanisms for host cell survival remain non-virulent. 
1.5 Clinical manifestations  
 
Salmonellosis infection can manifest itself in three major forms; enteritis, septicaemia and 
abortion (10). NTS are commonly associated with causing a mild self-limiting acute 
gastroenteritis, with a symptom onset 6-72 hours post ingestion. Symptoms of Salmonellosis 
include; fever, diarrhoea, abdominal pain and nausea, with infections typically lasting 
between four to seven days.  
Severe complications are possible if progression to an extra-intestinal infection occurs. 
Extra-intestinal infections of Salmonella can result in bacteraemia, septic arthritis, urinary 
tract infection, meningitis and osteomyelitis (17). Approximately 5% of individuals with NTS 
gastroenteritis could lead to bacteraemia (18). If unrecognised and untreated these 





1.6 Salmonellosis risk factors  
 
NTS occurrence tends to be seasonal, and is more commonly associated with the warmer 
summer months. Analysis of data collected from European countries (figure 1.3) provided 
evidence for a strong correlation between NTS infection and temperature (20). 
 
Figure 1.3 Cases of Salmonellosis within four European countries throughout the year (19) 
 -----: Average temperature (°C)           : Number of cases per week 
 
NTS extra-intestinal infection is relatively rare within developed countries, but is a common 
occurrence in developing countries. This manifestation has also been linked to those 








1.7 Antimicrobial therapy 
 
Antimicrobial therapy is not prescribed for the majority of NTS gastroenteritis as cases are 
usually self-limiting and typically resolve without the requirement for treatment. It was found 
that in otherwise healthy people, treatment with antimicrobials had no benefit over treatment 
without antimicrobials (21).  
Acheson & Hohmann (2001), suggested that antimicrobial therapy could actually prolong 
rather than limit the faecal shedding of the organism (18). It was reported that antimicrobials 
suppressed the microbiome in an animal model, allowing for the recrudescence of the 
organism (18). Therapy, however, is given to those presenting with a complicated illness or if 
a patient is at an increased risk of progression to extra-intestinal infections. Drugs commonly 
prescribed include, Ampicillin, Chloramphenicol, Trimethoprim and Tetracycline (22).  
1.7.1 Antimicrobial resistance in Salmonella 
 
Resistance to antimicrobials within NTS is now widespread in both developing and 
developed countries, significantly contributing towards to the public health burden (23). As a 
result of increasing antimicrobial resistance (AMR), treatment guidelines must be regularly 
reviewed (24).  Multiple Drug Resistance (MDR), defined as resistance to three or more 
antimicrobial classes, has been identified in many organisms and has been reported in 
numerous countries. Serotypes with reported MDR include; Agona, Anatum, Derby, Dublin 
and Typhimurium (25). A particular concern is the emergence of S. Typhimurium Definitive 
Type 104 (DT104) (26). The DT104 phage type was first recognised in 1984 in the United 
Kingdom where it displayed resistance to five antimicrobial agents; Ampicillin, 
Chloramphenicol, Streptomycin, Sulfamethoxazole and Tetracycline (27). Fluoroquinolones 
and third generation cephalosporins were previously recommended for treatment of DT104, 




Polymixins, discovered in 1947, are a group of cationic polypeptide antimicrobials consisting 
of five chemically different compounds (Polymixins A-E) (29).  Polymixin E, otherwise known 
as Colistin (figure 1.4), and Polymixin B are both synthesised from Bacillus spp., and are the 
only antimicrobials in this group used in clinical practice (30).  
15 
 
The cationic polypeptides interact with anionic lipopolysaccharide (LPS) molecules in the 
outer membrane, overall leading to the displacement of calcium and magnesium required for 
membrane stability (29). The overall effect of the drug results in leakage of cellular content 
and ultimately cell death (30). Due the large size of the antimicrobial it is active against Gram 
negative bacteria only.  
Colistin was first introduced into clinical practice in 1949, shortly after concerns were raised 
about side effects including nephrotoxicity and neurotoxicity (31). It was therefore no longer 
used and replaced with other agents such as the Cephalosporins. During this time Colistin 
use increased within veterinary medicine for disease prevention, cure and growth promotion.  
 
Figure 1.4 Structure of Colistin antibiotic (31) 
 
There is a growing threat of MDR organisms globally, especially within the Gram negative 
bacteria. The increased prevalence of MDR has drastically narrowed down therapeutic 
options leading to older drugs, including Colistin, to be resuscitated worldwide (30). The 
majority of countries restrict the use of Colistin, and is only prescribed as last line treatment 






1.8.1 Colistin resistance 
 
There has been a recent increase in reporting of Colistin resistance, most likely due to 
improper use within both clinical and veterinary fields. Resistance was primarily attributed to 
chromosomal mutations or insertion sequence (IS) elements (32). The modification of the 
LPS moiety through the addition of positively charged 4-amino-4-deoxy-L-arabinose (L-Ara4-
N) and phosphoethanolamine (PEtN) molecules, causes an overall negative charge of the 
outer membrane, preventing any interaction with Colistin (33).  
The most common mutations occur in regulatory genes involved with two component 
systems, mgrB, phoP/phoQ, pmrA, pmrB, pmrC and crrAMB (33). Mutations have also been 
described in genes involved with lipid A biosynthesis, lpxA, lpbxC and lpxD, leading to the 
complete loss of the LPS (29) 
1.8.2 mcr-1  
 
Due to a lack of complete understanding, it was assumed that Colistin resistance always 
occurred chromosomally, however in 2015 it was discovered that resistance can occur 
through a plasmid borne mobile Colistin resistance gene–  mcr (32). Routine surveillance on 
AMR in E.coli in pigs in China demonstrated a major increase in Colistin resistance (34). 
Conjugation experiments using the pig strain E.coli SHP45, demonstrated the ability of 
Colistin resistance to transfer to another strain suggesting horizontal gene transfer. 
Sequencing of the transconjugant revealed a plasmid, pHNSHP45 (figure 1.5), this was 
extracted and sequenced (34). Gene prediction and annotation for the plasmid was 
performed using databases Glimmer 3.02 and Basic Local Alignment Search Tool (BLAST), 
the putative Polymixin resistance gene was ligated into a cloning vector and transformed into 
an E.coli isolate (34). This study demonstrated that the plasmid mediated resistance gene 









Figure 1.5 Structure of pHNSHP45 plasmid. Encoded mcr-1 from E. coli strain SHP45 from a pig in 
China (34). 
 
It was suggested that mcr-1 encoded a phosphoethanolamine transferase (35), enabling a 
modification of PEtN moiety of lipid A resulting in the Colistin resistance (32). The global 
distribution of mcr-1 isolated from different organisms was determined in 2018 (36) (figure 
1.6). This study reported that Vietnam had the second highest number of mcr-1 positive 








Figure 1.6 Global location of mcr-1 isolated in animals, humans and environment (37). 
 
To date there have been eight different mcr genes identified (37). Mcr-1 to 3  was originally 
described as being present only on plasmids, however there is now evidence of the genes 
inserted into the chromosome (38).  
 
1.9 Pork Value in Vietnam 
 
Vietnam is a rapidly developing country with a population of 95 million (39). The hospitals 
are overcrowded, healthcare staff are under pressure and there is a lack of adequate 
diagnostic testing, as a result there is frequent and inappropriate prescribing of 
antimicrobials (40). Vietnam has received interest recently due its high burden of infectious 
disease. As a result of the countries unrestricted access to antimicrobials, it has become a 
hotspot for drug resistance (41) 
Pork accounts for greater than 70% of total meat consumption within Vietnam (42). It is 
mainly produced by smallholders and sold fresh at traditional wet markets across the 
country. It has become essential to manage food safety and animal disease in the pork value 
chains due to high levels of bacterial contamination, which could potentially lead to human 
infection (43).  
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1.10 Antimicrobial use within the agriculture sector in Vietnam 
 
Antimicrobial usage in animal production is thought to be a significant contributing factor to 
the global emerging AMR. Antimicrobial use is widespread within the Vietnamese agriculture 
sector for growth promotion, therapeutics and prophylaxis. The antimicrobials used are the 
same as those used in clinical cases, including the β-lactams, Aminoglycosides, Macrolides 
and Tetracyclines (41). A review on the antimicrobial presence in animal feed within Vietnam 
found 55.4% (377/680) of commercial pig feed contained at least one antimicrobial (44). 
Antimicrobials found in commercial pig feed included; Bacitracin 24.7%, Colistin 12.1%, 
Amoxicillin 1.1% and Neomycin 0.9% (44). 
Previously there has been little regulation of control of antimicrobials, farmers tend not 
comply with local policies and give a wide variety of drugs to their livestock. Over the past 
few years, due to the increased concern, the regulation of antimicrobial use within animals 
has increased. The Ministry of Agriculture and Rural Development (MARD) published a 
Decree 39/2017, which stated that by 2020 antimicrobials will not be permitted in animal 
feed (45).  
1.11 NTS in Vietnam 
 
In 2016 MLST was performed on invasive NTS isolates within Vietnam, the study concluded 
that the two main causes of invasive NTS infection were serotypes Enteritidis and 
Typhimurium, 43% and 30% respectively (46). As the main route of transmission to humans 
is through the ingestion of contaminated food, several studies have been interested in the 
prevalence of NTS within the agriculture sector.   
1.12 Reducing disease risks and improving food safety in Vietnam - PigRISK 
 
The PigRISK study of 2014/5 was conducted with an objective to improve food safety in 
smallholder pig value in Vietnam. The focus aimed two provinces in northern Vietnam – 
Hung yen and Nghe An (figure 1.7). A total of 217 pork samples were obtained from 













Figure 1.8 Highlighting the three districts within A- Hung yen province and B- Nghe An (43) 
 
A B A 
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It was found that 44.7% (97/217) were contaminated with NTS. Table 1.1 displays 
intermediate and resistance results to each class of antimicrobial tested. Serotypes identified 
included; S. Derby (n=23), S. Typhimurium (n=36), S. London (n=6), S. Anatum (n=4), S. 
Rissen (n=1) and S. Enteritidis (n=4).  
 
Table 1.1 Phenotypic antimicrobial susceptibility results for 97 NTS isolates from PigRISK 







Intermediate      
(n=97)
PigRISK samples 
Resistant       
(n=97)
Penicillins
Ampicillin 3 (3.1%) 54 (55.7%)
Piperacillin 11 (11.3%) 5 (5.2%)
Aminoglycosides
Gentamicin 13 (13.4%) 20 (20.6%)
3rd Generation cephalosporins
Cefotaxime 46 (47.4%) 1 (1.0%)
Ceftriaxone 15 (15.5%) 2 (2.1%)
Polymixins
Colistin 37 (38.1%) 33 (34.0%)
Fluoroquinolones
Nalidixic acid 12 (12.4%) 16 (16.5%)
Ciprofloxacin 68 (70.1%) 4 (4.1%)
Nitrofurans
Nitrofurantoin 2 (2.1%) 0 (0%)
Folate pathway inhibitor
Trimethoprim 0 (0%) 48 (49.9%)
Tetracyclines
Tetracycline 2 (2.1%) 45 (46.4%)
Phenicols




1.13 SafePORK, 2018 
 
SafePORK, 2018 aims to manage the food safety risks which were highlighted in the 
PigRISK project. Part of this study involves determining the NTS prevalence within the pork 
value chain. This will contribute towards improving the national action plan to reduce NTS 
contamination. The first round of sample collection will include pork samples from 




















 Aims and objectives  
 
Aims: 
 To observe and to analyse the patterns of NTS serotypes and AMR of isolates 
between 2014 to 2018 
 To determine whether Colistin resistance in the PigRISK study is caused by mcr-1  
Objectives: 
 Colistin resistant isolates will be resurrected from the stored PigRISK study collection 
 All PigRISK strains will be confirmed as NTS by serotyping 
 PigRISK strain resistance to Colistin will be confirmed using phenotypic methods 
 The incidence of mcr-1 will be ascertained by PCR identification 
 SafePORK samples will be screened for the presence of NTS 
 All SafePORK NTS strains will be screened for resistance to; Ampicillin, Gentamicin, 
Piperacillin, Cefotaxime, Ceftriaxone, Nitrofurantoin, Chloramphenicol, Trimethoprim, 
Tetracycline, Nalidixic acid and Colistin 
 
Hypothesis: 
There have been several reports indicating the presence of mcr-1 in Enterobacteriaceae 
within Vietnam. As Vietnam is a hotspot for drug resistance, we would expect to see the 
presence of this gene. Vietnamese government have recently tightened laws and regulation 
of antimicrobial use within agriculture, we would therefore expect to see a drop in resistance 









 Materials and Methods 
 
3.1 Preparation of agar and broths 
 
3.1.1 Muller-Kauffmann Tetrathionate-Novobiocin Broth (MKTTn) 
 
89.5g of dehydrated MKTTn (Merck, Germany) added to 1L sterile distilled water (DW). 
Mixture was heated using a microwave until dissolved, it was then allowed to cool to 
approximately 50 °C. 20ml Iodine Potassium solution (Merck, Germany) was then added, 
mixed by inversion, and 9ml aliquoted into test tubes.   
3.1.2 Rappaport Vassiliadis Semi-Solid agar (MSRV) 
 
15.8g of dehydrated MSRV (Merck, Germany) added to 500 ml DW. Mixture was heated 
using a microwave until dissolved, it was allowed to cool to approximately 50°C. 1ml DW 
was added to the freeze dried MSRV supplement. The entire supplement was added to the 
cooled agar, mixed by inversion, then poured into petri dishes and allowed to solidify. 
3.1.3 Xylose Lysine Tergitol 4 (XLT4) agar 
 
59g of dehydrated XLT4 (Merck, Germany) added to 1L DW. 46 ml XLT4 agar supplement 
added, then heated in a microwave until dissolved. It was allowed to cool to approximately 
50°C, then poured into petri dishes and allowed to solidify.  
3.1.4 Rambach agar 
 
30.5g of dehydrated Rambach (Merck, Germany) added to 1L DW, 10ml Rambach 
supplement added. Mixture heated in a microwave until dissolved, then allowed to cool to 
approximately 50°C. Agar then poured into petri dishes and allowed to solidify. 
3.1.5 Kligler agar  
 
55g of dehydrated Kligler (Merck, Germany) added to IL DW, heated in a microwave until 




3.1.6 IRIS Salmonella agar  
 
60.7g of dehydrated IRIS Salmonella (Biokar, France) added to 1L of DW. Heated in a 
microwave until dissolved. Cooled to 50°C, poured into petri dishes and then allowed to 
solidify. 
3.1.7 Nutrient agar (NA) 
 
20g of dehydrated nutrient agar (Merck, Germany) added to 1L of DW. Heated in a 
microwave until dissolved, then autoclaved at 121°C for 15 minutes. The agar was cooled to 
50°C then poured into petri dishes and allowed to solidify.  
3.1.8 Sven Gard semi-solid agar 
 
The ready to use agar was heated (Biorad, Germany) in a microwave until agar is 
completely molten. Allow to cool to 50°C.  
3.1.9 Muller-Hinton agar 
 
34.0g of Muller-Hinton (Merck, Germany) added to 1L of DW. Autoclaved at 121°C for 15 
minutes, cooled to 50°C then poured into petri dishes and allowed to solidify. 
3.1.10 Xylose lysine decarboxylase agar (XLD)  
 
55g of dehydrated XLD (Merck, Germany) added to 1L of DW. Heated in a microwave until 
dissolved. Agar allowed to cool to 50°C, then poured into petri dishes and allowed to solidify. 
3.1.11 Simmons Citrate agar  
 
22.5g of dehydrated Simmons Citrate (Merck, Germany)  added to 1L DW, heated in a 
microwave until dissolved, autoclaved at 121°C for 15 minutes then 5ml aliquoted into test 
tubes. 
3.1.12 Urea broth  
 
38.5g of dehydrated urea powder (Merck, Germany) added to 1L DW, heated in a 
microwave until dissolved, then 3ml aliquoted into test tubes. 
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3.1.13 Lysine decarboxylase broth  
 
14g of dehydrated lysine decarboxylase (Himedia, India) added to 1L DW, heated in a 
microwave until dissolved, then 5ml aliquoted into test tubes. 
3.1.14 Salmonella enrichment broth 
 
20.0g of dehydrated Salmonella enrichment broth (Biokar, France) added to 1L of DW. 




9g of Sodium Chloride (Xilong Chemical Company, China) added to 1L of DW and aliquoted 
5ml into test tubes. 
3.1.16 Muller-Hinton broth (MHB) 
 
21g Muller-Hinton broth (Merck, Germany) suspended in 1L of DW, aliquoted 5ml into test 
tubes and then autoclaved at 121 °C for 15 minutes. 
3.1.17 Buffered peptone water (BPW)  
 
25.5 g of Buffered peptone (Merck, Germany) added to 1L of DW and autoclaved at 121°C 
for 15 minutes. 
3.2 Strain resurrection 
 
To resurrect strains from -20°C storage, strains were defrosted first, then a 10µl loop was 
used to streak a selective IRIS Salmonella agar (section 3.1.6) and incubated at 37°C for 24 
hours. Strains which failed to grow on the selective agar were further enriched in 9ml 
Salmonella enrichment broth (section 3.1.14). Following incubation, at 37°C for 24 hours, a 
10µl loop was used to culture the enrichment broth onto XLD agar (section 3.1.10) and 
incubated for a further 24 hours at 37°C. All strains were then sub-cultured onto a non-




3.3 Salmonella Serotyping 
 
Serotyping was performed following the Kauffman and White scheme using both polyvalent 
and monovalent O and H antiserum (Biorad, Germany).  
3.3.1 O and H1 antigen identification 
 
One Salmonella colony was picked using a 1µl loop and was suspended in 1 drop of 
antiserum on a clear glass slide, tilted back and forth by hand for 1 minute and observed for 
agglutination (figure 3.1). Polyvalent antiserum was tested first to determine the antigen 
group, once established, monovalent antiserum was then tested to identify the exact antigen 
following figure 3.2 and figure 3.3.  
 
Figure 3.1 Suspension of Salmonella spp. colony with antisera. Left hand side showing a 







Figure 3.2 O antigen test flow chart. Indicating the monovalent antigens present within the 
polyvalent groups OMA, OMB and OMC (46) 
 
Figure 3.3 H antigen test flow chart. Indicating the monovalent antigens present within the 
polyvalent groups HMA, HMB, HMC and H:I (46) 
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3.3.2 H2 antigen identification, phase change 
 
To change the H phase of Salmonella, specific blocking antiserum was used, this was 
determined based on the H1 monovalent antigen(s) identified (table 3.1). One drop of the 
specific blocking antiserum was added to a petri dish. Then 4mls of the cooled Sven Gard 
semi-solid agar (section 3.1.8) was poured into the petri dish, mixed and then allowed to 
solidify. Using a 1µl loop, 1 colony was stabbed into the centre of the agar, and then 
incubated at 37°C for 24 hours. Following incubation a 1µl loop was used to collect 
Salmonella growth from the agar, this was then mixed with polyvalent H antiserum and then 
monovalent H antiserum (figure 3.3). Serotype identification was obtained through consulting 
the antigenic formulae of the Salmonella serotypes as published by WHO and the Pasteur 
Institute (2007). 















         l and v 











3.4 Antimicrobial resistance  
 
3.4.1 Disc diffusion 
 
Using a 1µl loop, 1-2 bacterial colonies were picked from the nutrient agar plate and 
inoculated into 5ml saline (section 3.1.15), creating a turbidity of 0.5 McFarland (MF) 
bacterial suspension. A sterile swab was dipped into the bacterial suspension, and then 
spread in three directions, creating a bacterial lawn on Muller-Hinton agar (section 3.1.9). 
Antimicrobial discs then placed on the agar using sterile forceps, no more than 6 discs on a 
plate. The agar was incubated at 37°C for 24 hours, following incubation zone sizes were 
measured and interpreted using guidelines provided by European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards 




Table 3.2 Antimicrobials tested and concentration using disc diffusion. 
 
3.4.2 Colistin Broth Microdilution (BMD) 
 
In a 96 well microtitre tray, 50µl MHB (section 3.1.16) was added to 5 wells. 100µl MHB was 
then added to the 6th well, as an antimicrobial free control. 16µg/ml Colistin Sulphate (Sigma-
Aldrich, America) was prepared by dissolving the antimicrobial powder in MHB. 50µl of this 
Colistin Sulphate preparation was added to the first well and serodiluted 4 times by taking 
50µl across, creating concentrations of 8, 4, 2, 1 and 0.5 µg/ml. Using a 1µl loop, 1-2 
bacterial colonies were picked from the nutrient agar plate and suspended in 5ml saline 
creating a turbidity of 0.5 MF. The bacterial suspension was then diluted 1:150 in MHB to 
obtain approximately 5 x 105 CFU/ml. 50µl of the bacterial MHB dilution was then added to 
each well in the microtitre tray, which was then incubated at 37°C for 24 hours. 
























3.5 Nucleic acid extraction methods 
 
3.5.1 GeneJET Genomic DNA purification Kit  
 
As per manufacturer (Thermofisher, USA) protocol, a heavy bacterial suspension was 
prepared by inoculating 4-5 colonies into 1ml of saline using a 1µl loop. The suspension was 
then centrifuged for 10 minutes at 5000xg, the supernatant was then discarded and the 
pellet re-suspended in 180µl of digestion solution. 20µl Proteinase K was added to this 
suspension, vortexed and incubated at 56°C for 30 minutes in a shaking water bath 
(JULABO, Germany). 20µl RNase A solution was added and incubated at room temperature 
for 10 minutes. 200µl Lysis solution and then 400µl of 50% ethanol were added.  
The prepared lysate was then transferred to a GeneJET Genomic DNA Purification Column 
inserted in a collection tube then centrifuged for 1 minute at 6000xg. The collection tube was 
discarded and the column transferred into a new tube. 500µl wash buffer I was added and it 
was then centrifuged for 1 minute at 8000xg. The flow through was discarded and the 
column placed back into the same collection tube. 500µl wash buffer II was added and it was 
centrifuged for 3 minutes at 12,000xg. The collection tube was emptied, the column was re-
centrifuged for 1 minute at 12,000xg to remove any residual solution. The collection tube 
was discarded, and the column transferred to a new sterile 1.5ml Eppendorf tube.  
200µl Elution buffer was added, it was incubated at room temperature for 2 minutes, and 
then centrifuged for 1 minute at 8000xg. Finally, the purification column was discarded and 
the purified DNA stored at -20°C until required.  
3.5.2 Boiling method  
 
4-5 bacterial colonies were collected using a 1µl loop from nutrient agar, and inoculated in 
1ml nuclease free water (NFW) was prepared and centrifuged at 1844xg for 10 minutes. The 
supernatant was discarded, the pellet re-suspended in 200µl NFW and centrifuged at 
1844xg for 10 minutes. The supernatant was removed, the pellet re-suspended in 500µl 
NFW, then placed in a Thermoblock at 100°C for 10 minutes and then in an icebox at 0°C 
for a further 10 minutes. The suspension was centrifuged at 14462xg for 1 minute and the 




3.5.3 NanoDrop  
 
To assess purity and concentration of the extracted DNA, 2µl of a selected extract was run 
on the Nanodrop spectrophotometer as per the manufacturer’s instructions. 




mcr-1 primers (Sigma-Aldrich, America) were prepared in NFW, to obtain a final 
concentration of 10µmol/µl. The primers used for this study were: 
Forward: CLR – F: 5'-CGGTCAGTCCGTTTGTTC-3' 
Reverse: CLR – R: 5'-CTTGGTCGGTCTGTAGGG-3' 
3.6.2 Mastermix preparation 
 
13.5µl of mastermix and 1.5µl extracted DNA were used for each PCR reaction. The 
mastermix for one reaction contained: 
 Water: 5.2µl 
 MyTaq HS (Bioline): 7.5µl 
 Forward Primer: 0.4µl 
 Reverse Primer: 0.4µl 
MyTaq HS Mix is a pre-prepared mix including DNA polymerase, dNTPs and MgCl2, details 
of concentrations are not provided by the manufacturer.  
3.6.3 PCR programme 
 
A mcr-1 positive and negative control were run alongside to ensure the correct functioning of 





Table 3.3 PCR programme used indicating temperature, time and number of cycles. 
 
3.7 Agarose electrophoresis 
 
1.5% agarose gel was prepared by dissolving 1.5g of agarose in 100ml 1xTAE buffer 
(Merck, Germany). The mixture was heated in a microwave until complete dissolution. The 
gel was allowed to cool to 50°C, before adding 5µl RedSafe (Intron biotechnology, South 
Korea).  
The gel was then poured into the tray until the comb teeth were about ½ into the agarose 
and allowed to solidify. Once solidified, the comb was removed, and the gel added to the 
electrophoresis tank. 1xTAE buffer was poured into the chamber to cover the top surface of 
the gel. 1µl of gel loading dye was mixed with 5µl amplicon. 5µl of the amplicon dye mix was 
then added to each well. A DNA ladder (SibEnzyme) off 100 base pair (bp) was included to 
provide a standardised base pair guide. The gel was run in 1xTAE buffer for 30 minutes at 
100V. The bands were observed using UV light illumination on the ImageQuant LAS 500 
(GE Healthcare, Sweden). 
3.8 NTS isolation, SafePORK 2018  
 
3.8.1 Qualitative isolation 
 
Following International Organisation for Standardisation (ISO) 6579, Salmonella spp. 
qualitative presence was determined through enrichment, isolation and confirmation. For 
non-selective enrichment, 25g of pork was added to 225ml BPW (section 3.1.17). The 
sample was then homogenised using the Stomacher 400 circulator (Seward, UK) and 
incubated at 37°C for 18 hours. 1 ml of the incubated sample medium was then enriched 
into 9ml MKTTn broth (section 3.1.1) and incubated at 37°C for 18 hours. Three separate 
20µl drops of incubated sample media were dispensed onto MRSV (section 3.1.2) and 
incubated at 41°C for 24 hours.  








Following 24 hours incubation, both MKTTn broth and MRSV were checked for positivity. 
The MKTTn broth will change from green to yellow and growth will appear on the MRSV 
agar if Salmonella positive (figure 3.4).  
 
Figure 3.4 Positive MKTTn broth and MRSV agar suggesting Salmonella isolation. A: MKTTn 
broth and B: MRSV agar. 
 
If no growth appeared on MRSV, it was further incubated at 41°C for another 24 hours. If 
there was no growth at 48 hours, it was reported as negative for Salmonella.  
Positive samples were then streaked onto XLT4 (section 3.1.3) and Rambach agar (section 
3.1.4) using a 1µl loop and incubated at 37°C for 18 hours. Following incubation, the agar 
was inspected for putative Salmonella spp. colonies.  Salmonella colonies on XLT4 
appeared pink with a black centre, and on Rambach appeared pink. All putative colonies on 
both XLT4 and Rambach were inoculated onto a Kligler agar slope (section 3.1.5), and 
incubated at 37°C for 18 hours. Following incubation, the Kligler agar was inspected for 
Hydrogen Sulphide (H2S), gas, and fermentation of glucose and lactose using the following 
criteria: 
 Alkaline slant (red), acidic butt (yellow) indicates fermentation of glucose only 
 Acidic slant (yellow), acidic slant (yellow) indicates fermentation of glucose and 
lactose 
 Alkaline slant (red), alkaline butt (red) indicates that neither glucose or lactose was 
fermented 
 Cracks or bubbles in the agar indicate gas production 
 Black precipitate in the butt indicates the production of H2S 
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On Kligler agar, Salmonella enterica appears an alkaline slant, acidic butt, H2S positive, gas 
positive (figure 3.5). 
 
 
Figure 3.5 Kligler agar positive result for Salmonella enterica (47) 
 
3.8.2 Biochemical tests  
 
Biochemical tests including; Urea broth (section 3.1.12), Simmons Citrate agar (section 
3.1.11) and Lysine Decarboxylase broth (section 3.1.13) were then set up on any suspected 
colonies. All biochemical tests were incubated at 37°C for 24 hours. Biochemical tests were 
interpreted following table 3.4. S. enterica is citrate positive, urea negative and lysine 
decarboxylase positive. Positive Salmonella isolates were then cultured onto NA (section 




Table 3.4 Biochemical test positive and negative interpretation 
 
 
3.8.3 Most Probable Number (MPN) 
 
Quantitative testing was also performed on samples using the Most Probable Number (MPN) 
method. 25g of pork sample was added to 225ml BPW and homogenised. Serial dilutions 
(10-1, 10-2 and 10-3) were then prepared in 9ml of BPW and incubated at 37°C for 24 hours. 
Following incubation, 20µl of each serial dilution suspension was added to 3 separate MRSV 
agar plates and incubated at 41°C for 48 hours. Positive samples were then cultured onto 
Rambach agar and a Kligler slope. Biochemical tests (section 3.8.2) were set up for 













Biochemical test Positive Negative
Urea Pink broth Yellow-orange broth
Citrate Blue colonies Green colonies
Lysine Decarboxylase Purple broth Yellow broth
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 Results  
 
4.1 Section 1: Analysis of Colistin resistant NTS strains from PigRISK 2014/5 
 
4.1.1 PigRISK overview 
 
The PigRISK project was conducted between April 2014 and February 2015 with the main 
objective to improve food safety in smallholder pig value in Vietnam. In this study, 1275 pig 
product and environmental samples were collected from farms, slaughterhouses and 
traditional markets within two provinces in northern Vietnam; Hung yen and Nghe An. It was 
found that NTS was prevalent in 435 samples (34.1%). Of the PigRISK positive strains 
isolated, 293 were then serotyped and AMR tested.  
For the first part of this study, the objective was to determine whether the Colistin resistance 
observed in the PigRISK study is caused by mcr-1. Within this study, strains isolated from 
environmental samples were excluded, this was to ensure only pig NTS strains were 
analysed not environmental contamination.  
4.1.2 PigRISK sample selection 
 
NTS strains to be used within this study were selected from the PigRISK collection based on 
sample type (pork, carcass swab, mesenteric lymph node and faeces), and for Colistin 
resistance. 30/293 (6.9%) NTS isolates fitted this criteria; this included 18 strains (13 wet 
market, 5 slaughterhouse) from Hung Yen province and 12 strains (8 wet market, 4 
slaughterhouse) from Nghe An province (appendix 1). The 30 selected NTS strains were 
obtained from -20°C storage (section 3.2).  
4.1.3 PigRISK strain serotyping re-check  
 
Serotyping of all 30 selected strains was performed following section 3.3. The antigenic 
formula was then used to identify the serotype by referring to the WHO and the Pasteur 
Institute (2007) publication. 
Serotyping antigenic formula example: 
Salmonella enterica serotype Typhimurium: 1, 4, 12: i: 1, 2.  
This strain has O antigens 1, 4 and 12, H antigen i (phase 1) and H antigen 1, 2 (phase 2).  
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All 30 strain serotypes correctly matched with those previously reported in PigRISK. 
Serotypes include; S. Typhimurium (n=13), S. Derby (n=4), S. Enteritidis (n=3), S. London 
(n=2), S. Stanley (n=2), S. Assinie (n=1), S. Hadar (n=1), S. Weltevreden (n=1) and 
Unknown (n=3).  
4.1.4 NTS Colistin reduced susceptibility  
 
PigRISK strains had been previously tested for Colistin AMR using the disc diffusion method 
only. For this study, Colistin sulphate (Oxoid, USA) 10µg disc diffusion (section 3.4.1) was 
performed as a re-check on 15 randomly selected strains. Alongside the disc diffusion, BMD 
(section 3.4.2) was performed to determine the Minimum Inhibitory Concentration (MIC) on 
all 30 strains. For both disc diffusion and broth microdilution quality control was performed by 
using a Colistin susceptible organism, E.coli ATCC 25922 and a Colistin resistant (mcr-1 
positive) organism E.coli NCTC 13846.  
No zone diameter breakpoints for Colistin are provided in guidelines for either EUCAST or 
CLSI. Zone sizes were interpreted following the method in PigRISK, using data published by 
Gales et al. This paper defined zone criteria and interpretation for Colistin as, ≤11mm 
resistant, and ≥14mm sensitive (47). Both control strains had passed, however only two 









Table 4.1 Colistin disc diffusion zone sizes and interpretation.  ID: Identification, PR: PigRISK 
 
The MIC was determined from the BMD as the last well showing complete inhibition of 
bacteria (figure 4.1). Following EUCAST guidelines for broth microdilution the Colistin MIC 





Figure 4.1 Broth micro-dilution result for a Colistin resistant positive control at various 
concentrations (8, 4, 2, 1 and 0.5 µg/ml). MIC is recorded as 4µg/ml as growth appears in 2, 1 and 
0.5µg/ml, indicating resistance to Colistin. 
Out of the 30 strains tested, 19 were resistant to Colistin by MIC determination (table 4.2). 
The 11 strains which showed sensitivity to Colistin were not included any further in this 
study. 
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NCTC 13846
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4.2 Polymerase Chain Reaction (PCR) for mcr-1  
 
For the confirmed Colistin resistant strains (table 4.2), PCR was then performed to 
determine whether the resistance observed was caused by mcr-1. To determine whether the 
gene is located on the chromosome or a plasmid, all 19 confirmed Colistin resistant strains 
were extracted for nucleic acid using both the GeneJET kit (section 3.5.1) and the boiling 
method (section 3.5.2) respectively. To ensure the extractions were successful and pure, all 
DNA extractions were run on NanoDrop (section 3.5.3, table 4.3).  
Table 4.3 DNA extraction purity check, absorbance at 260/280nm for both extraction methods. 







Concentration      
(ng/µl)
Absorbance        
(260/280nm)
PR2 105.1 2.04 37.4 1.79
PR3 66.9 2 13 1.75
PR5 65.6 1.93 9.3 1.74
PR6 53.9 1.86 11.4 1.67
PR7 70 1.86 11.4 1.72
PR8 56 1.89 20.1 1.81
PR9 42.6 1.8 15.8 1.67
PR10 21.4 1.61 26.8 1.7
PR13 38.3 1.72 17.9 1.72
PR14 39.7 1.8 18 1.81
PR15 39.8 1.77 20.5 1.75
PR19 30.7 1.73 17.8 1.8
PR21 49.5 1.85 17.8 1.65
PR22 31.4 1.75 21.9 1.65
PR23 45.3 1.84 19.9 1.73
PR24 27.5 1.73 25.3 1.74
PR27 34.4 1.78 25.2 1.72
PR28 53 1.89 19.7 1.76
PR29 51.1 1.87 17.7 1.67
Positive control 
E.coli NCTC 13846
59.1 1.7 35.5 1.76
Negative control 
E.coli  ATCC 25922
56.5 1.81 30.3 1.79
Boilate extraction method GeneJET extraction method
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DNA Purity is defined in the manufacturer guidelines as an absorbance 260/280 ratio of 
around 1.8. In this study as all readings were around 1.8 the extraction methods were 
therefore successful. The DNA concentrations are varied, however even in low 
concentrations if the gene is present it will still be detected when amplified and run on gel 
electrophoresis. 
4.2.1 mcr-1 presence on the chromosome  
 
Bacterial chromosomes were extracted using the GeneJET kit (section 3.5.1). Control strains 
were amplified first to optimise the procedure. E.coli NCTC 13846 was used as the mcr-1 
positive control, and E.coli ATCC 25922 as the negative control. The mcr-1 was amplified 
using primers described by the National Food Institute, 2016 (section 3.6.1) using PCR 
mastermix (3.6.2) and PCR cycling conditions (3.6.3). Amplicons were identified using a 
1.5% agarose gel (2.7). A 308bp amplicon was expected for a positive result (48). As 
expected E.coli NCTC 13846 did not amplify a product of the expected size, no bands 
appeared on the gel (figure 4.2). 
                                
Figure 4.2 Gel electrophoresis, 1.5% agarose UV image result. Lane 1: 100bp ladder, 2: mcr-1 
negative control, 3: mcr-1 positive control. 
 
4.2.2 mcr-1 presence on a plasmid  
 
Whole genome was extracted using boilates (section 3.5.2). The mastermix was prepared 
(section 3.6.2) then run on PCR programme (section 3.6.3). Amplicons were run on 1.5% 
agarose gel and bands were seen in the positive control lane (figure 4.3).  















As the band appears around 300bp, this would indicate mcr-1 positivity and its likely 
presence on a plasmid.  
 
Figure 4.3 Gel electrophoresis 1.5% agarose UV image result. Lane 1: 100bp ladder, 2: mcr-1 
negative control, 3: mcr-1 positive control. 
 
4.2.3 PCR – PigRISK strains, presence of mcr-1 
 
As mcr-1 identification had been optimised, the PigRISK strains were subsequently tested 
for both chromosomal and plasmid location of mcr-1. PCR results showed the positive 
control amplicon, however no visual bands were seen in any PigRISK test strains extracted 
by both GeneJET (figure 4.4) and boiling method (figure 4.5). Indicating that mcr-1 was not 
present on either the chromosome or the plasmid within this sample selection.  
 






















Figure 4.4 Chromosomal analysis of mcr-1 gene. 1.5% agarose gel electrophoresis UV image 





4.2.4 Colistin analysis summary  
 
Re-checking the Colistin AMR results from the PigRISK study highlighted discrepancies with 
previous reporting. In PigRISK all AMR was performed using the disc diffusion method, 
however EUCAST and CLSI guidelines do not recommend this method for Colistin AMR due 
to the potential for false resistance. Using this method for the re-check, only 2 strains 
appeared to be resistant. Using the recommended method, BMD, 19/30 strains were 
confirmed as Colistin resistant. The strains found to be sensitive by BMD were not included 
any further in this study. 
The 19 resistant strains were extracted following two methods to determine whether the mcr-
1 was the cause of the resistance, and whether it was located on the plasmid or the 
chromosome. To ensure the DNA had been extracted successfully in both methods, the 
extractions were run on NanoDrop. It was confirmed that DNA had been correctly extracted, 


















Figure 4.5 Plasmid analysis of mcr-1 gene. 1.5% agarose gel electrophoresis UV image 





4.3 Section 2: Analysis of SafePORK NTS strain serotypes and AMR patterns  
 
4.3.1 SafePORK overview 
 
The second objective in this study is to observe and to analyse the patterns of NTS 
serotypes and antibiograms of isolates between 2014 and 2018. A study, SafePORK 
involved collecting pork samples which were then tested for NTS contamination. These 
SafePORK samples will represent 2018 in this study. 
4.3.2 Sample selection 
 
42 Pork meat samples were collected in total from 6 convenience stores and 6 supermarkets 
across Hanoi, Vietnam (figure 4.6). 12 pork samples were collected from convenience stores 
and 30 samples from supermarkets.  
 




4.3.3 NTS prevalence within Hanoi food retailers 
 
NTS was isolated using a qualitative (3.8.1) and quantitative approach (3.8.3). The 
qualitative approach used various selective agars to isolate Salmonella, any presence was 
then confirmed through using biochemical tests (3.8.2). It was found that 78.6% (33/42) of 
total samples collected from both convenience stores and supermarkets were found to be 
contaminated with NTS. The prevalence in convenience store was 83.3% (10/12), compared 
with 76.7% (23/30) in the supermarket.   
The quantitative approach was used in order to calculate the MPN (appendix 2). The MPN is 
an estimate the population density of viable microorganisms within a test sample. This is 
calculated using data provided by De Man J.C (1983) (49). The median MPN/g count for this 
study was 7.5 (range 0.36-120).  
4.4 SafePORK Serotyping 
 
Serotyping of the 33 SafePORK strains by the Kauffman an White serotyping scheme (see 
2.3) identified S. Anatum (n=4), S. Typhimurium (n=4), S. Rissen (n=4), S. Lamberhurst 
(n=1), S. Derby (n=3), S. Alfort (n=1), S. Newport (n=1), S. Goldcoast (n=1), S. Give (n=1), 
S. Meleagridis (n=3), S. Stanley (n=1), S. Agona (n=1), S. London (n=2) and Unknown 
(n=6).  
4.5 SafePORK AMR; disc diffusion and BMD 
 
AMR disc diffusion was performed following 3.4.1, Colistin was tested using the broth 
microdilution method (section 3.4.2) to obtain the MIC. AMR results for both disc diffusion 
and broth microdilution are shown in appendix 3 and summarised in table 4.4. Zone sizes 
were determined by following guidance provided by EUCAST and CLSI. No resistance was 
seen to Cefotaxime, Ceftriaxone, Colistin, Ciprofloxacin and Nitrofurantoin. Whereas high 
levels of resistance was seen with Ampicillin (69.7%), Tetracycline (57.6%), 
Chloramphenicol (63.6%) and Trimethoprim (60.6%). It was found that 63.6% of SafePORK 




Table 4.4 Summary of number and percentage of SafePORK strains (n=33) showing sensitivity, 
intermediate and resistance to 12 antimicrobials tested 
 
 
4.6 SafePORK summary  
 
Out of the total 43 pork samples collected from supermarkets and convenience stores 
around Hanoi, 33 were found to be contaminated with 13 known NTS serotypes. The 
predominant serotype was Typhimurium, which was only isolated from the supermarkets. 
Serotypes Anatum and Rissen were isolated from both retailers. The prevalence of NTS 
didn’t differ much between convenience store 83.3% (10/12), and the supermarket 76.7% 
(23/30). AMR results indicated a high level of multidrug resistance, however no resistance 
was reported in antibiotics; Cefotaxime, Ceftriaxone, Ciprofloxacin, Nitrofurantoin and 
Colistin.  
 
Class and antimicrobial Sensitive Intermediate Resistant
Penicillins
Ampicillin 10 (30.3%) 0 (0%) 23 (69.7%)
Piperacillin 16 (48.5%) 10 (30.3%) 7 (21.2%)
Aminoglycosides
Gentamicin 30 (90.9%) 0 (0%) 3 (9.1%)
3rd Generation 
cephalosporins
Cefotaxime 33 (100%) 0 (0%) 0 (0%)
Ceftriaxone 33 (100%) 0 (0%) 0 (0%)
Polymixins
Colistin 33 (100%) 0 (0%) 0 (0%)
Fluoroquinolones
Nalidixic acid 30 (90.9%) 0 (0%) 3 (9.1%)
Ciprofloxacin 33 (100%) 0 (0%) 0 (0%)
Nitrofurans
Nitrofurantoin 33 (100%) 0 (0%) 0 (0%)
Folate pathway inhibitor
Trimethoprim 13 (39.4%) 0 (0%) 20 (60.6%)
Tetracyclines
Tetracycline 12 (36.4%) 2 (6.1%) 19 (57.6%)
Phenicols







Limitations with diagnostics and bacterial surveillance within the Vietnamese medical care 
system has led to a lack of knowledge and understanding surrounding NTS human 
infections. It is known that the most likely route of human NTS infection is through the 
consumption of contaminated meat, this study aimed to provide reliable data on NTS 
prevalence within the pork value chain. Providing better control of NTS contamination within 
the porcine reservoir would overall reduce any transmission to humans during consumption.  
 
5.2 Colistin resistance re-check 
 
Colistin AMR in the PigRISK study was performed using the disc diffusion method, however 
there are no EUCAST or CLSI breakpoints. Zone sizes were interpreted using data 
published by Gales et al, 2001. Disc diffusion is not a reliable technique for Colistin, the large 
size of the antimicrobial results in poor agar diffusion, leading to small zones and the 
potential for the incorrect interpretation of results. The original PigRISK study reported 15 
strains being resistant, however when re-checked only 2 strains appeared resistant and 13 
appeared sensitive. This could potentially be a result of human error whilst determining and 
interpreting the zone sizes of the original data, however it is more likely that false resistance 
occurred due to the size and the diffusion of the antimicrobial.  
To ensure that we only included Colistin resistant strains within this study, the MIC was 
obtained for all 30 selected strains. Using the BMD method, 19/30 strains were resistant. 11 
strains which were reported as resistant in the original report were determined as sensitive 
through MIC testing. This strongly suggested false resistance occurring in the original data, 
further demonstrating the unreliability of the disc diffusion method. The two strains which 
appeared resistant in the disc diffusion re-check were confirmed as resistant by MIC, evident 
that this disc diffusion result was not caused by false resistance. The strains which were 
sensitive in disc diffusion re-check, then confirmed sensitive by BMD were excluded from 





As the original data was not reproducible, and the re-check demonstrated why the disc 
diffusion method is not reliable, the original data cannot be accepted. What is unclear, and 
not demonstrated by this re-check is whether false sensitivity also occurred in the original 
study. This study focused on the Colistin resistant PigRISK strains and excluded all sensitive 
strains. All strains in PigRISK would therefore need to be re-tested using the recommended 
broth microdilution method to ensure false sensitivity or resistance does not occur. 
5.3 mcr-1 prevalence  
 
There has been a lot of recent focus surrounding Colistin resistance since the discovery of 
mcr-1. Over the past few years it has become a clinically important antimicrobial and is 
currently used as a last resort drug for MDR organisms such as the Enterobacteriaceae. The 
mobile resistance gene poses a substantial public health risk due to its ability to cause rapid 
resistance, and also preventing treatment options for patients with MDR bacteria. It is 
imperative that global control measures, including surveillance, are put into practice to 
prevent the spread of mcr-1. It was previously thought that the mcr-1 occurred only on a 
plasmid, however, a paper recently published provided evidence for mcr-1 on a chromosome 
(50). Chromosomal location provides stability whereas if on a plasmid the gene could easily 
be lost.  
This study did not identify mcr-1 presence on chromosome or plasmid in any of the 19 
strains tested. The Colistin resistance observed in this study was therefore not caused by 
mcr-1. This study only looked into the one gene causing Colistin resistance, however this is 
not the only gene able to cause Colistin resistance, the most common cause of resistance 
occurs with mutations in regulatory genes involved with two component systems (33). As a 
hotspot for drug resistance, it is not a surprise that genes causing Colistin resistance have 
been reported in Vietnam. The presence of both mcr-1 and mcr-3 has been identified by 
Yamaguchi et al. in Ho Chi Minh City (2018), there have been no reports published of 
presence of any other mcr in Vietnam. To determine the exact cause of the Colistin 
resistance observed in this study, it would be necessary to perform Whole Genome 
Sequencing (WGS). The sequence could be compared with other known resistant strains to 





5.4 NTS prevalence between 2014/5 to 2018 
 
The PigRISK pork samples (2014/5) were collected from traditional wet markets in 
predominantly rural provinces, whereas the SafePORK samples (2018), were collected from 
local supermarkets and convenience stores around urban Hanoi. This study found to have a 
much higher NTS contamination rate in SafePORK (78.6%) than the traditional wet market 
from PigRISK (44.7%). It can speculated that the cause of this increase is due to the larger 
production scale in the urban area, leading to the increased risk of contamination. To test 
this theory, it would be necessary to collect samples and information from the 
slaughterhouses in both urban and rural settings to determine the prevalence of NTS. There 
is a higher demand for pork in the urban area, so the number of pigs slaughtered per day is 
higher. It is likely that cleaning between each slaughter may not be as meticulous as within 
the rural area due to time pressures, leading to an increased chance for NTS contamination.  
It is also possible that adequate hygiene practices are not being implemented, or followed in 
supermarkets of convenience stores whilst preparing meat for sale. The contamination could 
also be caused by storage time. Pork in the traditional markets is usually sold out within the 
same morning, whereas in supermarkets the storage time before selling can be considerably 
longer. To determine the practices within the retail stores in Hanoi, an observational study 
could be performed to determine whether good hygienic standards are in place, and whether 
the meat is being stored in the correct facilities.  
The high prevalence could also be attributed to poor hygiene practices when processing the 
pork, or poor ascetic procedures within the laboratory. In order to determine whether the 
contamination was not caused by the laboratory, it would be interesting to collect swab 
samples around the laboratory to ensure the sterilisation methods are efficient.  
5.5 Serotype comparison 2014/5 to 2018 
 
S. Typhimurium was the predominant serotype identified in both PigRisk (37.1%) and 
SafePORK (12.1%) pork samples. This was expected as Typhimurium has been reported as 
the most commonly isolated serotype globally (51). There were similarities between other 
serotypes identified, however six serotypes were identified in SafePORK that were not in 
PigRISK. This occurrence could be a result of changes in the dominant serotype over time, 
however it is more likely to be a result of varying locations for sample collections. 
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This study only included a small sample size, therefore it is unlikely to be representative of 
the variety of serotypes present. More samples would need to be obtained for a better 
comparison with the PigRISK study.  
5.6 AMR comparison between 2014/5 to 2018  
 
An increase in resistance was reported from PigRisk to SafePORK in the antimicrobials; 
Ampicillin (55.7% to 69.7%), Trimethoprim (49.9% to 60.6%), Tetracycline (46.4% to 57.6%) 
and Chloramphenicol (46.4% to 63.6%). These antimicrobials are the common first line 
drugs prescribed for a serious NTS infection, so it was expected to see a high level of 
resistance. Antimicrobials are easily obtained from a pharmacy without a prescription, so 
individuals are likely to seek therapy even in self-limiting cases, resulting in unnecessary 
treatment. 
If resistance is seen in the first line antimicrobials, a fluoroquinolone or a 3rd generation 
cephalosporin would then be prescribed. Within this study no resistance was seen to 
Ciprofloxacin or either 3rd generation cephalosporins tested. However, if current practices 
resume, it will only be a matter of time until these antimicrobials will also become resistant. 
Further implementation of the national plan is required to lower the levels of resistance, and 
improved diagnostic testing is essential to ensure correct therapy is prescribed. Antimicrobial 
resistance is a multi-dimensional threat to public health due to the increased and 
uncontrolled use of antimicrobials in both humans and livestock.  
The Vietnamese government now understands the importance of control and surveillance of 
antimicrobial use, and so have started to put regulations into order. It was stated that by 
2020 antimicrobials will be not be permitted for in animal feed growth promotion or 
prophylaxis. This control measure is a step in the right direction, however antimicrobials can 
still be obtained from veterinary clinics without prescription. 
No resistance to Colistin was observed in SafePORK, this is interesting as Van Cuong et al. 
had reported that 12.1% of Vietnamese commercial pig feed containing Colistin in 2016 (44). 
It is hoped that the recent control of antimicrobials in pig feed is the cause of this significant 
decrease. An increase was seen in MDR strains, this is critical issue globally as it limits 






5.7 Limitations  
 
The study was limited by time and available resources. Conducting the study within a low to 
middle income country meant that laboratory resources were not readily available, and 
would take several weeks to arrive once ordered. As a result of this, the study was limited to 
determining the presence of one gene causing Colistin resistance. The time available 
restricted the number of SafePORK samples we could test. Due to delays in sample 
collection, this study only focused on pork samples collected from convenience stores and 
supermarkets in Hanoi.  
5.8 Conclusions 
 
This study included two aims, the first to observe NTS prevalence and to analyse patterns of 
serotypes and AMR of isolates between 2014/5 to 2018. The NTS prevalence was predicted 
to be lower in SafePORK isolates compared to the PigRISK isolates due to better storage 
facilities (i.e <4°C) in supermarkets, compared to the traditional wet markets (no cooling and 
environmental contamination). From this study we observed an increase in prevalence 
between 2014/5 to 2018, suggesting contamination issues within the retail market. As a 
result of the government tightening regulations on antimicrobials within animal feed, we 
hypothesised that we would see a resistance decrease in the antimicrobials banned from 
feed. This study found no resistance within several antimicrobial classes, including Colistin. 
Colistin was previously included within animal feed, as no resistance was seen in this study 
it is a potential indicator that the government ban is having a positive effect. 
The second aim was to determine whether Colistin resistance in the PigRISK study was 
caused by mcr-1. It was hypothesised that some Colistin resistant strains in our study would 
be a result of this gene. While no mcr-1 was found, it has been reported within Vietnam, 
therefore surveillance and vigilance would be required to prevent spread.  
MDR has become major global concern, antimicrobial treatment options are limited leading 
to complications when treating infections. Vietnam is a hotspot for drug resistance as a result 
of years of unnecessary treatment regimens and overuse in livestock feed. What is unclear 
is whether how likely transmission actually occurs from pigs to humans, and what the 
implications are. Is transmission from a pig more likely to cause a mild or serious infection 
than from another animal? Improving diagnostics, reporting and surveillance could be a step 





To continue on from this project there are several recommendations. In the PigRISK study, 
Colistin AMR results should not be accepted and should be repeated using the 
recommended method to ensure correct reporting. In this study mcr-1 was not determined 
as being the cause of the Colistin resistance observed in PigRISK. To understand the exact 
cause of the PigRisk Colistin resistance, whole genome sequencing could be used to detect 
the gene responsible.  
To aid further comparison with the PigRisk study using statistical analysis, it is necessary to 
collect a variety of samples covering the entire pork value chain. As high NTS prevalence in 
pork in Hanoi was highlighted in this study, increasing the sample size and including the 
entire value chain would also enable us to compare the NTS prevalence at each stage of 
production. This high prevalence is concerning, and the source of the contamination must be 
determined in order to implement control measures and guidance. Information regarding the 
processes used during each stage within the pork value chain will provide an insight into the 
likely source of contamination.  
To determine whether changes in local practices had affected the NTS prevalence and 
AMR, samples should be collected from the same locations as taken in PigRISK. This would 
allow for a direct comparison, and would indicate whether control action plans suggested in 
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ID Province Pork Chain Sample type Serotype
PR1 Hung Yen Market Pork Typhimurium
PR2 Hung Yen Market Pork Typhimurium
PR3 Hung Yen Market Pork Typhimurium
PR4 Hung Yen Market Pork Stanley
PR5 Hung Yen Market Pork Enteritidis
PR6 Hung Yen Market Pork Enteritidis
PR7 Hung Yen Market Pork Typhimurium
PR8 Hung Yen Market Pork Derby
PR9 Hung Yen Market Pork Unknown
PR10 Hung Yen Market Pork Typhimurium
PR11 Hung Yen Market Pork Unknown
PR12 Hung Yen Market Pork Derby
PR13 Hung Yen Slaughterhouse Lymph node Typhimurium
PR14 Hung Yen Slaughterhouse Carcass swab Typhimurium
PR15 Hung Yen Slaughterhouse Faeces Typhimurium
PR16 Hung Yen Slaughterhouse Lymph node Typhimurium
PR17 Hung Yen Slaughterhouse Faeces Typhimurium
PR18 Hung Yen Market Pork Derby
PR19 Nghe An Market Pork Typhimurium
PR20 Nghe An Market Pork Hadar
PR21 Nghe An Market Pork Typhimurium
PR22 Nghe An Slaughterhouse Faeces Weltevreden
PR23 Nghe An Slaughterhouse Carcass swab Derby
PR24 Nghe An Market Pork Stanley
PR25 Nghe An Market Pork Assinie
PR26 Nghe An Market Pork Typhimurium
PR27 Nghe An Slaughterhouse Carcass swab London
PR28 Nghe An Market Pork London
PR29 Nghe An Market Pork Enteritidis
PR30 Nghe An Slaughterhouse Lymph Node Unknown
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Appendix 2: Most Probable Number (MPN) of NTS per gram of sample 
3 MRSV agar plates were inoculated with each dilution (1.0, 0.1, 0.01), positive tube results 





ID 1 0.1 0.01 MPN/g
SP1 1 1 0 0.74
SP2 1 0 0 0.36
SP4 0 0 1 0.3
SP5 1 0 0 0.36
SP6 1 0 0 0.36
SP7 1 1 0 0.74
SP8 2 1 0 1.5
SP9 3 3 1 46
SP10 3 0 0 2.3
SP11 3 3 0 24
SP12 2 0 0 0.92
SP14 3 1 1 7.5
SP15 3 3 3 120
SP16 2 0 0 0.92
SP17 3 2 1 15
SP18 3 3 2 110
SP20 3 3 1 46
SP21 2 0 0 0.92
SP22 3 3 3 120
SP24 3 3 2 110
SP25 3 3 2 110
SP26 3 2 0 9.3
SP27 3 2 0 9.3
SP28 2 1 0 1.5
SP29 1 0 0 0.36
SP31 2 1 0 1.5
SP33 1 0 0 0.36
SP34 2 2 2 3.5
SP36 3 1 2 12
SP37 3 1 1 7.5
SP39 3 2 1 15
SP40 3 2 0 9.3




Appendix 3: AMR  
1. Disc diffusion raw data results of 6 antimicrobials. Zone sizes and interpretation. ID: 
strain identification, SP: SafePORK, AMP: Ampicillin, CN: Gentamicin, NA: Nalidixic 




ID AMP CN NA F CIP TET
SP1 25 (S) 21 (S) 24 (S) 16 (S) 39 (S) 22 (S)
SP2 6 (R) 23 (S) 28 (S) 27 (S) 36 (S) 6 (R)
SP4 6 (R) 25 (S) 27 (S) 23 (S) 35 (S) 6 (R)
SP5 6 (R) 23 (S) 28 (S) 27 (S) 40 (S) 12 (I)
SP6 6 (R) 28 (S) 28 (S) 19 (S) 31 (S) 8 (R)
SP7 6 (R) 27 (S) 26 (S) 23 (S) 34 (S) 6 (R)
SP8 6 (R) 20 (S) 23 (S) 20 (S) 25 (S) 6 (R)
SP9 23 (S) 24 (S) 27 (S) 19 (S) 34 (S) 27 (S)
SP10 6 (R) 24 (S) 24 (S) 26 (S) 29 (S) 21 (S)
SP11 21 (S) 28 (S) 24 (S) 28 (S) 39 (S) 13 (I)
SP12 6 (R) 28 (S) 6 (R) 25 (S) 31 (S) 9 (R)
SP14 21 (S) 25 (S) 29 (S) 21 (S) 39 (S) 20 (S)
SP15 6 (R) 19 (S) 22 (S) 25 (S) 28 (S) 6 (R)
SP16 22 (S) 23 (S) 30 (S) 23 (S) 42 (S) 6 (R)
SP17 20 (S) 22 (S) 27 (S) 26 (S) 35 (S) 25 (S)
SP18 19 (S) 23 (S) 25 (S) 17 (S) 32 (S) 23 (S)
SP20 6 (R) 28 (S) 24 (S) 24 (S) 33 (S) 6 (R)
SP21 21 (S) 22 (S) 26 (S) 20 (S) 33 (S) 24 (S)
SP22 6 (R) 10 (R) 21 (S) 20 (S) 28 (S) 23 (S)
SP24 19 (S) 27 (S) 24 (S) 28 (S) 34 (S) 9 (R)
SP25 6 (R) 24 (S) 22 (S) 20 (S) 29 (S) 6 (R)
SP26 6 (R) 27 (S) 6 (R) 29 (S) 31 (S) 6 (R)
SP27 6 (R) 26 (S) 25 (S) 27 (S) 30 (S) 6 (R)
SP28 6 (R) 6 (R) 20 (S) 19 (S) 26 (S) 19 (S)
SP29 6 (R) 6 (R) 24 (S) 23 (S) 30 (S) 25 (S)
SP31 6 (R) 21 (S) 27 (S) 21 (S) 33 (S) 6 (R)
SP33 29 (S) 19 (S) 26 (S) 20 (S) 31 (S) 26 (S)
SP34 6 (R) 22 (S) 22 (S) 20 (S) 35 (S) 6 (R)
SP36 6 (R) 21 (S) 25 (S) 27 (S) 37 (S) 6 (R)
SP37 6 (R) 22 (S) 6 (R) 20 (S) 27 (S) 16 (S)
SP39 6 (R) 22 (S) 24 (S) 25 (S) 28 (S) 6 (R)
SP40 6 (R) 22 (S) 25 (S) 17 (S) 27 (S) 6 (R)
SP41 6 (R) 21 (S) 24 (S) 23 (S) 38 (S) 6 (R)
AMR disc diffusion zone sizes (mm) and interpretation
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2. Disc diffusion and BMD MIC results of 6 antimicrobials, zone sizes and interpretation. 
ID: strain identification, SP: SafePORK, CHL: Chloramphenicol, CTX: Cefotaxime, 






ID CHL CTX CRO PIP W Col
SP1 30 (S) 29 (S) 27 (S) 24 (S) 29 (S) 0.5 (S)
SP2 6 (R) 35 (S) 35 (S) 21 (S) 6 (R) 0.5 (S)
SP4 6 (R) 32 (S) 32 (S) 17 (I) 6 (R) 0.5 (S)
SP5 30 (S) 31 (S) 31 (S) 21 (S) 6 (R) 0.5 (S)
SP6 6 (R) 34 (S) 33 (S) 19 (I) 6 (R) 2 (S)
SP7 6 (R) 34 (S) 34 (S) 20 (S) 6 (R) 0.5 (S)
SP8 6 (R) 30 (S) 31 (S) 15 (R) 6 (R) 0.5 (S)
SP9 32 (S) 34 (S) 32 (S) 32 (S) 28 (S) 0.5 (S)
SP10 6 (R) 29 (S) 30 (S) 14 (R) 6 (R) 0.5 (S)
SP11 31 (S) 30 (S) 29 (S) 30 (S) 30 (S) 0.5 (S)
SP12 6 (R) 32 (S) 32 (S) 18 (I) 6 (R) 0.5 (S)
SP14 30 (S) 34 (S) 32 (S) 30 (S) 29 (S) 0.5 (S)
SP15 6 (R) 35 (S) 34 (S) 17 (I) 6 (R) 0.5 (S)
SP16 31 (S) 35 (S) 32 (S) 31 (S) 28 (S) 0.5 (S)
SP17 29 (S) 33 (S) 32 (S) 28 (S) 30 (S) 0.5 (S)
SP18 30 (S) 33 (S) 31 (S) 29 (S) 26 (S) 1 (S)
SP20 6 (R) 29 (S) 31 (S) 17 (I) 31 (S) 1 (S)
SP21 28 (S) 27 (S) 29 (S) 27 (S) 29 (S) 0.5 (S)
SP22 6 (R) 33 (S) 32 (S) 21 (S) 6 (R) 0.5 (S)
SP24 31 (S) 30 (S) 33 (S) 27 (S) 30 (S) 0.5 (S)
SP25 6 (R) 30 (S) 31 (S) 20 (S) 6 (R) 0.5 (S)
SP26 6 (R) 33 (S) 34 (S) 23 (S) 30 (S) 0.5 (S)
SP27 6 (R) 31 (S) 31 (S) 19 (I) 6 (R) 0.5 (S)
SP28 6 (R) 30 (S) 31 (S) 18 (I) 6 (R) 0.5 (S)
SP29 6 (R) 32 (S) 32 (S) 19 (I) 6 (R) 0.5 (S)
SP31 6 (R) 33 (S) 34 (S) 16 (R) 6 (R) 0.5 (S)
SP33 28 (S) 32 (S) 31 (S) 25 (S) 26 (S) 0.5 (S)
SP34 6 (R) 35 (S) 33 (S) 18 (I) 6 (R) 0.5 (S)
SP36 6 (R) 30 (S) 31 (S) 14 (R) 6 (R) 0.5 (S)
SP37 26 (S) 35 (S) 30 (S) 16 (R) 27 (S) 0.5 (S)
SP39 6 (R) 32 (S) 28 (S) 15 (R) 6 (R) 0.5 (S)
SP40 6 (R) 34 (S) 33 (S) 17 (I) 6 (R) 0.5 (S)
SP41 6 (R) 35 (S) 28 (S) 15 (R) 6 (R) 0.5 (S)




































































Appendix 5: Student Questionnaire  
Candidate No: 111010   MSc: Medical Microbiology 
 
Project Supervisor: Dr. Fred Unger and Dr. Richard Stabler 
 
Project Title: Antimicrobial resistance analysis of Non-Typhoidal Salmonella in 
porcine from Northern Vietnam 
 
As part of our assessment procedure for student projects we are asking you to complete the 
following short questionnaire.  Please tick the most appropriate statements in each section and 
bind it into your project.  A copy of this questionnaire must be included in your finished 
project report.  
 
(Please ensure you tick the correct box) 
 
Who initiated the project?  
  My supervisor 
  Me 
 
How much help did you get in developing the project? 
  none:   I decided on the design alone 
  some:  I used my initiative but was helped by suggestions from my supervisor 
  substantial: My supervisor had most say, but I added ideas of my own 
  maximal: I relied on the supervisor for ideas at all stages 
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  not applicable:  the nature of the project was such that I had minimal opportunity to contribute to the design  
 
How much help did you get in carrying out the work for the project? 
  none: I worked alone with no supervisor input 
  minimal: I worked alone with very little supervisor input 
  appropriate: I asked for help when needed 
  substantial:  the supervisor gave me more assistance than expected  
  excessive:  the supervisor had to give me excessive assistance to enable me to get data 
 
What was the degree of technical difficulty involved? 
  slight:  data easily obtained 
  moderate:  data were moderately difficult to obtain 
  substantial:  data were difficult to obtain 
  
How much help were you given in the analysis and interpretation of any results? 
  none   
  standard:  My supervisor discussed the results with the me and advised on statistics and presentation 
  substantial: My supervisor pointed out the significance of the data and told me how to analyse it 
 
How much help were you given in finding appropriate references? 
  none  
  some: only a few references were provided 
  substantial: most references were given by my supervisor 




How much help did you get in writing the report? 
  none: my supervisor did not see the report until it was submitted 
  minor: my supervisor saw and commented on parts of the report 
  standard: my supervisor saw and commented on the first draft of the report 
  substantial:  my supervisor gave more assistance than standard 
How much time was spent on the project? 
  too little to expect adequate data* 
  sufficient 
  too much* 
 
*if too little or too much, were there any reasons for it, e.g. unforeseen technical problems, lack of materials, 
etc.? 
 
During the course of the work was your contact with your supervisor 
  Daily 
  Weekly 
  Monthly 
  Varied but at regular intervals 
  Never 
Was this contact with your supervisor 
  too infrequent 
  infrequent but sufficient 
  frequent but not excessive 




Please comment on your experiences during the  project 
My project at first was difficult due to delays in sample collection and determining the project plan. As soon as 
this was sorted I was able to start work within the laboratory collecting results.  
I thoroughly enjoyed my project, I have learnt new skills and gained an insight into the research field. My 
supervisor was always able to help and give advice.  
 
 
THIS QUESTIONNAIRE MUST BE INCLUDED INTO YOUR PROJECT REPORT 
 
 
 
 
  
 
 
